小智港股覆盤 | 5月3日
今日，港股三大指數漲跌互現。截止收盤，恆生指數漲0.06%，報21101點。國企指數跌0.43%，報7267點。恆生科技指數跌1.38%，報4409點。市場約825只個股上漲，805只個股下跌。成交額突破1067.05億港幣，和昨天同期相比下跌35.38%。
盤面上，消費信貸板塊漲幅較前。鼎豐集團控股漲超10%；51信用卡、大中華金融等多股漲超5%；易鑫集團、威華達控股等多股漲超2%。51信用卡附屬公司授出800萬元貸款。
海運板塊活躍。永豐集團控股漲超4%；中遠海控、海豐國際、太平洋航運等多股漲超3%；珠江船務漲超1%。中遠海控(601919.SH)一季度淨利潤276.17億元，同比增長78.73%；Aggregate of abrdn plc affiliated investment management entities減持太平洋航運276.7萬股，每股作價約3.49港元。
貿易經銷板塊活躍。兆邦基地產漲超11%；昊天國際建投、普匯中金國際、亞洲先鋒娛樂等多股漲超10%；森信紙業集團漲超5%。昊天國際建投4月28日根據股份獎勵計劃發行850萬股；普匯中金國際擬1.32億元出售匯景國際(西安)信息科技全部股權。
電腦與外圍設備板塊跌幅居前。寶新金融跌超5%；SPROCOMM INTEL、小米集團-W等多股跌超4%；富通科技跌超2%；研祥智能跌超1%。寶新金融擬8億元出售深圳邦凱新能源75.50%股權；印度稱小米非法滙款，在銀行戶口檢獲相當於57億港元資金。
生物科技板塊走低。康方生物-B、復宏漢霖等多股跌超10%；榮昌生物-B跌超9%；歌禮制藥-B、創勝集團-B等多股跌超8%。復宏漢霖：HLX26聯合漢斯狀®用於治療晚期轉移性實體瘤或淋巴瘤的臨牀試驗申請獲國家藥品監督管理局批準；榮昌生物-B第一季度淨虧損約2.87億元；創勝集團-B在2022年ASCO年會展示TST001及MSB0254臨牀試驗數據最新業務進展。
汽車板塊走低。理想汽車-W跌超5%；蔚來-SW跌超4%；長城汽車跌超3%；小鵬汽車-W、北京汽車等多股跌超1%。理想汽車4月交付4,167輛理想ONE，按月減少62.2%；蔚來4月交付汽車5,074輛，按月減49.2%；瑞銀下調長汽目標價至16元，評級「買入」。
uSMART智能寫手的信息、數據均來自媒體公開報道，智能寫手不能保證其完全準確，內容僅供參考，不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
